Health News

Kaiser Health News: Biden’s July Executive Order Includes Drug Pricing Provisions. But Will They Do Enough?

·         Nearly six months into his term, Biden issued an executive order on promoting economic competition, which included moves toward fulfilling these promises. KHN has teamed up with our partners at PolitiFact to analyze Biden’s promises during the 2020 presidential campaign — and, so far, experts generally say the jury is still out on how meaningful these efforts will be.

·         Vox: The harrowing new reality for Alzheimer’s patients

·         The FDA approved Aduhelm over the objections of its own scientific advisers, who said the mixed evidence of its benefits did not outweigh the known risks. The agency has now called for an independent investigator to probe the approval process. Medicare has begun a months-long process to decide whether it should cover Aduhelm and for whom, and several private health insurers have said they won’t cover the drug, given the limited evidence of its effectiveness. Last week, the Cleveland Clinic and Mount Sinai, two of the best-known hospital systems in the US, said they wouldn’t administer it for the same reason.